Breaking News Instant updates and real-time market news.

2021-02-17 16:07:51 MFIN Medallion Financial $7.30 / +0.68 (+10.27%) 16:07 02/17/21 02/17 16:07 02/17/21 16:07	Medallion Financial reports Q4 EPS 26c, consensus 25c Reports book value per share $9.30 vs. $10.68 last year. Medallion Bank's Tier 1 leverage ratio at quarter-end was 16.93%. Total assets were $1.6B as of December 31, 2020. The company said, "We stayed the course of tightening our credit and underwriting criteria during the year. Application volumes remained high, and growth continued, while net-charge offs remained low, demonstrating the strength of those portfolios. We look forward to building on the momentum our consumer segments have shown this past year. In addition, we continue to focus on the build-out of our fintech Strategic Partnership Program at Medallion Bank where volume was up in January. We believe we will sign our second partnership in the next 60 days and that this line of business will grow in 2021. We received payments from the medallion loans and other assets of $12.8 million in the fourth quarter and recorded $6.7 million of recoveries for the year. We continue to prioritize recoveries as we have significantly reduced our medallion loan exposure year over year. In the fourth quarter we lowered our New York City medallion values from $90,300 net to $79,500 net which ultimately contributed to a medallion segment loss of $3.6 million for the quarter. Our net interest margin remained strong in the fourth quarter at 8.89%, as the higher yielding consumer portfolio continues to perform while the medallion loans have been impaired and placed on non-accrual."	18 Feb
MFIN Medallion Financial $7.30 / +0.68 (+10.27%) 11/24/20 B. Riley Securities Medallion Financial resumed with a Buy at B. Riley Securities 04/30/20 B. Riley Securities Medallion Financial price target lowered to $7 from $10 at B. Riley FBR

2021-02-17 16:07:51

MFIN

Medallion Financial

$7.30 / +0.68 (+10.27%)

16:07

02/17/21

02/17

16:07

02/17/21

16:07

Medallion Financial reports Q4 EPS 26c, consensus 25c

Reports book value per share $9.30 vs. $10.68 last year. Medallion Bank's Tier 1 leverage ratio at quarter-end was 16.93%. Total assets were $1.6B as of December 31, 2020. The company said, "We stayed the course of tightening our credit and underwriting criteria during the year. Application volumes remained high, and growth continued, while net-charge offs remained low, demonstrating the strength of those portfolios. We look forward to building on the momentum our consumer segments have shown this past year. In addition, we continue to focus on the build-out of our fintech Strategic Partnership Program at Medallion Bank where volume was up in January. We believe we will sign our second partnership in the next 60 days and that this line of business will grow in 2021. We received payments from the medallion loans and other assets of $12.8 million in the fourth quarter and recorded $6.7 million of recoveries for the year. We continue to prioritize recoveries as we have significantly reduced our medallion loan exposure year over year. In the fourth quarter we lowered our New York City medallion values from $90,300 net to $79,500 net which ultimately contributed to a medallion segment loss of $3.6 million for the quarter. Our net interest margin remained strong in the fourth quarter at 8.89%, as the higher yielding consumer portfolio continues to perform while the medallion loans have been impaired and placed on non-accrual."

18
Feb

MFIN Medallion Financial

$7.30 / +0.68 (+10.27%)

11/24/20 B. Riley Securities: Medallion Financial resumed with a Buy at B. Riley Securities

04/30/20 B. Riley Securities: Medallion Financial price target lowered to $7 from $10 at B. Riley FBR

TODAY'S FREE FLY STORIES

Recommendations	Playa show see cash flow inflection no later than Q4, says Deutsche Bank » 07:18 03/08/21 03/08 07:18 03/08/21 07:18 PLYA Playa Hotels & Resorts $6.85 / -0.05 (-0.72%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly PLYA Playa Hotels & Resorts $6.85 / -0.05 (-0.72%) 01/21/21 Davidson Kempner reports 8.46% passive stake in Playa Hotels & Resorts 11/16/20 Hilton La Romana reopens following temporary closure 11/04/20 Playa Hotels & Resorts to sell the Dreams Puerto Aventuras for $34.5M 10/08/20 Playa Hotels & Resorts resumes normal operations at Yucatan resorts PLYA Playa Hotels & Resorts $6.85 / -0.05 (-0.72%) 01/11/21 Macquarie Playa Hotels & Resorts price target raised to $8 from $7 at Macquarie 12/15/20 Citi Playa Hotels & Resorts upgraded to Neutral from Sell at Citi 07/02/20 Citi Playa Hotels & Resorts price target raised to $3 from $1 at Citi 04/29/20 SunTrust Playa Hotels & Resorts downgraded to Hold from Buy at SunTrust PLYA Playa Hotels & Resorts $6.85 / -0.05 (-0.72%) 03/04/21 Playa Hotels & Resorts reports Q4 EPS (55c), consensus (45c) 11/04/20 Playa Hotels & Resorts reports Q3 EPS (57c), consensus (45c) 07 Jan 19 Nov PLYA Playa Hotels & Resorts $6.85 / -0.05 (-0.72%) 03/04/21 Fly Intel: After-Hours Movers 01/06/21 Fly Intel: After-Hours Movers
Hot Stocks	Passage Bio to start PBFT02 clinical program in 1H21 » 07:18 03/08/21 03/08 07:18 03/08/21 07:18 PASG Passage Bio $19.83 / +0.44 (+2.27%) Passage Bio is advancing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PASG Passage Bio $19.83 / +0.44 (+2.27%) 07:17 Today Passage Bio to start Phase 1/2 trial of PBKR03 in 1H21 07:16 Today Passage Bio to dose first patient in global Imagine-1 study in Q1 07:15 Today Passage Bio receives Fast Track designations for PBGM01, PBFT02, PBKR03 03/03/21 Passage Bio announces anticipated upcoming milestones PASG Passage Bio $19.83 / +0.44 (+2.27%) 05:06 Today Chardan Passage Bio price target raised to $45 from $35 at Chardan 03/04/21 Citi Citi remains buyer of Passage Bio into first clinical data 03/04/21 Goldman Sachs Passage Bio upgraded to Buy from Neutral at Goldman Sachs 02/04/21 Fly Intel: Top five analyst initiations PASG Passage Bio $19.83 / +0.44 (+2.27%) 03/03/21 Passage Bio reports Q4 EPS (85c), consensus (70c) 11/10/20 Passage Bio reports Q3 EPS (63c), consensus (76c) 22 Jan PASG Passage Bio $19.83 / +0.44 (+2.27%) 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/22/21 Fly Intel: Wall Street's top stories at midday PASG Passage Bio $19.83 / +0.44 (+2.27%) 12/09/20 Nine new option listings on December 9th
Hot Stocks	Passage Bio to start Phase 1/2 trial of PBKR03 in 1H21 » 07:17 03/08/21 03/08 07:17 03/08/21 07:17 PASG Passage Bio $19.83 / +0.44 (+2.27%) Passage Bio is developing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PASG Passage Bio $19.83 / +0.44 (+2.27%) 07:16 Today Passage Bio to dose first patient in global Imagine-1 study in Q1 07:15 Today Passage Bio receives Fast Track designations for PBGM01, PBFT02, PBKR03 03/03/21 Passage Bio announces anticipated upcoming milestones 02/19/21 Passage Bio appoints Maxine Gowen to board of directors PASG Passage Bio $19.83 / +0.44 (+2.27%) 05:06 Today Chardan Passage Bio price target raised to $45 from $35 at Chardan 03/04/21 Citi Citi remains buyer of Passage Bio into first clinical data 03/04/21 Goldman Sachs Passage Bio upgraded to Buy from Neutral at Goldman Sachs 02/04/21 Fly Intel: Top five analyst initiations PASG Passage Bio $19.83 / +0.44 (+2.27%) 03/03/21 Passage Bio reports Q4 EPS (85c), consensus (70c) 11/10/20 Passage Bio reports Q3 EPS (63c), consensus (76c) 22 Jan PASG Passage Bio $19.83 / +0.44 (+2.27%) 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/22/21 Fly Intel: Wall Street's top stories at midday PASG Passage Bio $19.83 / +0.44 (+2.27%) 12/09/20 Nine new option listings on December 9th
Hot Stocks	Passage Bio to dose first patient in global Imagine-1 study in Q1 » 07:16 03/08/21 03/08 07:16 03/08/21 07:16 PASG Passage Bio $19.83 / +0.44 (+2.27%) PBGM01 is being studied… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PASG Passage Bio $19.83 / +0.44 (+2.27%) 07:15 Today Passage Bio receives Fast Track designations for PBGM01, PBFT02, PBKR03 03/03/21 Passage Bio announces anticipated upcoming milestones 02/19/21 Passage Bio appoints Maxine Gowen to board of directors 02/08/21 Passage Bio's IND application for Krabbe disease candidate cleared by FDA PASG Passage Bio $19.83 / +0.44 (+2.27%) 05:06 Today Chardan Passage Bio price target raised to $45 from $35 at Chardan 03/04/21 Citi Citi remains buyer of Passage Bio into first clinical data 03/04/21 Goldman Sachs Passage Bio upgraded to Buy from Neutral at Goldman Sachs 02/04/21 Fly Intel: Top five analyst initiations PASG Passage Bio $19.83 / +0.44 (+2.27%) 03/03/21 Passage Bio reports Q4 EPS (85c), consensus (70c) 11/10/20 Passage Bio reports Q3 EPS (63c), consensus (76c) 22 Jan PASG Passage Bio $19.83 / +0.44 (+2.27%) 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/22/21 Fly Intel: Wall Street's top stories at midday PASG Passage Bio $19.83 / +0.44 (+2.27%) 12/09/20 Nine new option listings on December 9th
Hot Stocks	Passage Bio receives Fast Track designations for PBGM01, PBFT02, PBKR03 » 07:15 03/08/21 03/08 07:15 03/08/21 07:15 PASG Passage Bio $19.83 / +0.44 (+2.27%) Passage Bio announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PASG Passage Bio $19.83 / +0.44 (+2.27%) 03/03/21 Passage Bio announces anticipated upcoming milestones 02/19/21 Passage Bio appoints Maxine Gowen to board of directors 02/08/21 Passage Bio's IND application for Krabbe disease candidate cleared by FDA 01/28/21 Passage Bio annoounces FDA IND clearance for PBFT02 PASG Passage Bio $19.83 / +0.44 (+2.27%) 05:06 Today Chardan Passage Bio price target raised to $45 from $35 at Chardan 03/04/21 Citi Citi remains buyer of Passage Bio into first clinical data 03/04/21 Goldman Sachs Passage Bio upgraded to Buy from Neutral at Goldman Sachs 02/04/21 Fly Intel: Top five analyst initiations PASG Passage Bio $19.83 / +0.44 (+2.27%) 03/03/21 Passage Bio reports Q4 EPS (85c), consensus (70c) 11/10/20 Passage Bio reports Q3 EPS (63c), consensus (76c) 22 Jan PASG Passage Bio $19.83 / +0.44 (+2.27%) 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/22/21 Fly Intel: Wall Street's top stories at midday PASG Passage Bio $19.83 / +0.44 (+2.27%) 12/09/20 Nine new option listings on December 9th

Hot Stocks	Victory Capital announces Alderwood secures FCA authorization » 07:15 03/08/21 03/08 07:15 03/08/21 07:15 VCTR Victory Capital $24.55 / +0.94 (+3.98%) Victory Capital reported… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options VCTR Victory Capital $24.55 / +0.94 (+3.98%) 02/10/21 Victory Capital reports AUM of $146.2B as of January 31 01/13/21 Victory Capital reports AUM $147.2B on December 31 01/13/21 Victory Capital reports AUM of $147.2B on December 31, 2020 12/10/20 Victory Capital reports November-end AUM of $142.5B vs. $131.1B prior month VCTR Victory Capital $24.55 / +0.94 (+3.98%) 11/19/20 Fly Intel: Top five analyst downgrades 11/19/20 BofA Victory Capital double-downgraded to Underperform from Buy at BofA 10/16/20 B. Riley Securities Victory Capital price target raised to $24 from $22 at B. Riley Securities 07/09/20 Barclays Victory Capital price target raised to $21 from $19 at Barclays VCTR Victory Capital $24.55 / +0.94 (+3.98%) 02/10/21 Victory Capital reports Q4 adjusted EPS $1.07, consensus $1.02 11/04/20 Victory Capital reports Q3 adjusted EPS $1.00, consensus 93c 05/13/21 Victory Capital VCTR Victory Capital $24.55 / +0.94 (+3.98%) 01/06/21 Fifteen new option listings on January 6th
Recommendations	Western Digital price target raised to $80 from $65 at Deutsche Bank » 07:14 03/08/21 03/08 07:14 03/08/21 07:14 WDC Western Digital $68.09 / +4.61 (+7.26%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WDC Western Digital $68.09 / +4.61 (+7.26%) 01/28/21 Western Digital jumps 5% to $55.32 after Q2 earnings beat 12/16/20 Intel announces next generation of memory and storage products 11/12/20 Twist, Illumina, Western Digital partner with Microsoft over DNA data storage 10/26/20 Dropbox among first to qualify Western Digital's new SMR HDDs WDC Western Digital $68.09 / +4.61 (+7.26%) 03/04/21 Goldman Sachs Western Digital upgraded to Buy from Neutral at Goldman Sachs 03/01/21 Barclays Western Digital price target raised to $75 from $53 at Barclays 02/25/21 Mizuho Western Digital price target raised to $80 from $65 at Mizuho 02/24/21 Benchmark Benchmark says Biden order bodes well for Nova Measuring, other semi suppliers WDC Western Digital $68.09 / +4.61 (+7.26%) 01/28/21 Western Digital sees Q3 adjusted EPS 55c-75c, consensus 64c 01/28/21 Western Digital reports Q2 adjusted EPS 69c, consensus 54c 01/28/21 Notable companies reporting after market close 10/28/20 Western Digital sees Q2 EPS 40c-60c, consensus 64c WDC Western Digital $68.09 / +4.61 (+7.26%) 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says 10/20/20 Swedish regulators ban Huawei, ZTE from upcoming 5G networks, Reuters reports WDC Western Digital $68.09 / +4.61 (+7.26%) 03/04/21 Fly Intel: After-Hours Movers 01/29/21 Boeing double upgrade among today's top calls on Wall Street 01/28/21 Fly Intel: After-Hours Movers 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference WDC Western Digital $68.09 / +4.61 (+7.26%) 02/24/21 Western Digital call volume above normal and directionally bullish 02/18/21 Early notable gainers among liquid option names on February 18th 02/17/21 Western Digital call volume above normal and directionally bullish 02/11/21 Early notable gainers among liquid option names on February 11th
Hot Stocks	Mesa Air reports 20,457 block hours in February » 07:14 03/08/21 03/08 07:14 03/08/21 07:14 MESA Mesa Air $12.58 / -0.39 (-3.01%) Mesa Air Group reported… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options MESA Mesa Air $12.58 / -0.39 (-3.01%) 03/02/21 Mesa Air enters conditional agreement to develop European JV 02/23/21 Mesa Air signs LOI to lease additional 737-400F cargo aircraft 02/18/21 Mesa Air reports 25,359 block hours in January 02/11/21 Mesa Air and United Airlines reach agreement with Archer Aviation MESA Mesa Air $12.58 / -0.39 (-3.01%) 03/04/21 Fly Intel: Top five analyst downgrades 03/04/21 Deutsche Bank Mesa Air downgraded to Hold after 100% rally at Deutsche Bank 03/03/21 Deutsche Bank Mesa Air downgraded to Hold from Buy at Deutsche Bank 02/17/21 Fly Intel: Top five analyst upgrades MESA Mesa Air $12.58 / -0.39 (-3.01%) 02/09/21 Mesa Air reports Q1 EPS 39c, consensus 3c MESA Mesa Air $12.58 / -0.39 (-3.01%) 02/09/21 Fly Intel: After-Hours Movers 12/09/20 Fly Intel: After-Hours Movers 11/25/20 Fly Intel: Pre-market Movers MESA Mesa Air $12.58 / -0.39 (-3.01%) 12/09/20 Mesa Air options imply 18.0% move in share price post-earnings
Hot Stocks	McAfee to sell enterprise business to STG-led consortium for $4B in cash » 07:14 03/08/21 03/08 07:14 03/08/21 07:14 MCFE McAfee $21.22 / -0.09 (-0.42%) McAfee announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options MCFE McAfee $21.22 / -0.09 (-0.42%) 02/22/21 Intrusion appoints Gary Davis as CMO 12/10/20 McAfee declares 8.7c per share quarterly dividend 12/04/20 McAfee Chief Product Officer Ashutosh Kulkarni resigns effective January 1 11/11/20 Microsoft appoints Christopher Young as EVP, business development MCFE McAfee $21.22 / -0.09 (-0.42%) 02/24/21 Deutsche Bank Deutsche upgrades McAfee on 'best-in-class' consumer security unit 02/24/21 Mizuho McAfee price target raised to $26 from $25 at Mizuho 02/24/21 Citi McAfee price target raised to $21 from $18 at Citi 02/24/21 Deutsche Bank McAfee upgraded to Buy from Hold at Deutsche Bank MCFE McAfee $21.22 / -0.09 (-0.42%) 02/23/21 McAfee sees Q1 revenue $725M-$735M, consensus $724.42M 02/23/21 McAfee reports Q4 EPS (73c), consensus 31c 11/19/20 McAfee sees Q4 revenue $732M-$742M, consensus $728.2M 11/19/20 McAfee reports Q3 EPS breakeven, consensus 35c 22 Oct MCFE McAfee $21.22 / -0.09 (-0.42%) 02/23/21 Fly Intel: After-Hours Movers 02/18/21 Wells Fargo, Seagate upgrades among today's top calls on Wall Street 11/19/20 Fly Intel: After-Hours Movers 10/18/20 Opening Day: Array jumps after $1.05B IPO MCFE McAfee $21.22 / -0.09 (-0.42%) 11/17/20 Three new option listings and three option delistings on November 17th
Hot Stocks	Harbor Custom Development acquires 48 acres in Washington for $3.9M » 07:13 03/08/21 03/08 07:13 03/08/21 07:13 HCDI Harbor Custom Development $2.96 / +0.01 (+0.34%) Harbor Custom Development… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Syndicate On The Fly HCDI Harbor Custom Development $2.96 / +0.01 (+0.34%) 02/24/21 Harbor Custom Development closes on 29 developed lots for $4.34M 02/22/21 Harbor Custom Development to sell 99 lots in Soundview Estates to Lennar 01/26/21 Harbor Custom Development to acquire 22 developed lots in Rocklin, CA 01/22/21 Harbor Custom Development acquires land for $9.4M in Austin area HCDI Harbor Custom Development $2.96 / +0.01 (+0.34%) 11/23/20 Harbor Custom Development sees 2021 gross revenues $70M 11/23/20 Harbor Custom Development sees 2020 gross revenues $47M 13 Jan 07 Aug HCDI Harbor Custom Development $2.96 / +0.01 (+0.34%) 01/25/21 Fly Insider: OncoCyte, Air Transport among week's notable insider trades 11/23/20 Fly Intel: Pre-market Movers

Upgrade	Waitr Holdings upgraded to Buy from Hold at Deutsche Bank » 07:13 03/08/21 03/08 07:13 03/08/21 07:13 WTRH Waitr Holdings $3.20 / +0.205 (+6.86%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WTRH Waitr Holdings $3.20 / +0.205 (+6.86%) 03/04/21 Waitr Holdings jumps 24% to $3.70 after expanding into cannabis delivery 03/04/21 Waitr Holdings expands into cannabis market 02/22/21 Waitr Holdings to integrate with Ordermark 11/17/20 Waitr Holdings' Ortale acquires over 266,000 common shares WTRH Waitr Holdings $3.20 / +0.205 (+6.86%) 05:58 Today Deutsche Bank Waitr Holdings upgraded to Buy from Hold at Deutsche Bank 03/05/21 B. Riley Securities Waitr share price offers opportunity ahead of results, says B. Riley 11/10/20 B. Riley Securities Waitr Holdings price target lowered to $7 from $8 at B. Riley Securities 07/22/20 B. Riley FBR B. Riley FBR starts Waitr at Buy, calls attractive takeout candidate WTRH Waitr Holdings $3.20 / +0.205 (+6.86%) 11/09/20 Waitr Holdings reports Q3 EPS 4c, consensus 5c WTRH Waitr Holdings $3.20 / +0.205 (+6.86%) 03/05/21 Fly Intel: Wall Street's top stories for Friday 03/05/21 Fly Intel: Wall Street's top stories at midday 03/04/21 Fly Intel: After-Hours Movers 11/18/20 Fly Intel: Pre-market Movers 00:00 Today Media, Internet and Telecom Virtual Conference 17:00 Today Waitr Holdings - WTRH
Hot Stocks	Baudax Bio appoints Richard Casten as CFO » 07:12 03/08/21 03/08 07:12 03/08/21 07:12 BXRX Baudax Bio $1.22 / +0.025 (+2.09%) , REPH Recro Pharma $3.28 / -0.365 (-10.03%) Baudax Bio (BXRX)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events BXRX REPH BXRX Baudax Bio $1.22 / +0.025 (+2.09%) 11/20/20 Baudax Bio announces publication of ANJESO Network Meta-Analysis 11/19/20 Baudax Bio announces additional Orange Book listed patent for ANJESO 11/09/20 Baudax Bio reduces headcount by approx. 40 professionals 10/20/20 Baudax Bio says ANJESO launch underway, entered into exchange agreements REPH Recro Pharma $3.28 / -0.365 (-10.03%) 02/26/21 Recro Pharma initiates reorganization to enhance operations 02/11/21 Recro Pharma announces key appointments in management team 12/16/20 Recro Pharma appoints David Enloe as president, CEO BXRX REPH BXRX Baudax Bio $1.22 / +0.025 (+2.09%) 05/15/20 JMP Securities Baudax Bio initiated with an Outperform at JMP Securities REPH Recro Pharma $3.28 / -0.365 (-10.03%) 01/04/21 Craig-Hallum Recro Pharma initiated with a Buy at Craig-Hallum 05/12/20 Oppenheimer Recro Pharma price target lowered to $12 from $18 at Oppenheimer BXRX REPH BXRX Baudax Bio $1.22 / +0.025 (+2.09%) 02/16/21 Baudax Bio reports 2020 EPS ($3.93), consensus ($4.29) 11/09/20 Baudax Bio reports Q3 EPS 62c, consensus (74c) REPH Recro Pharma $3.28 / -0.365 (-10.03%) 02/26/21 Recro Pharma sees Q1 revenue up approx. 65%-70% vs. Q4, two est. $17.64M 02/26/21 Recro Pharma reports Q4 EPS (48c), two est. (25c) 11/09/20 Recro Pharma reports Q3 EPS (9c), two est. (20c) 24 Mar 03/16/21 31st Annual Healthcare Virtual Conference
Hot Stocks	Eventbrite provides February operating update » 07:12 03/08/21 03/08 07:12 03/08/21 07:12 EB Eventbrite $22.73 / -0.12 (-0.53%) Eventbrite provided an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly EB Eventbrite $22.73 / -0.12 (-0.53%) 02/25/21 Eventbrite sees modest pace of recovery in paid ticket volume, revenue in 1H 09/16/20 Eventbrite says paid tickets grew 17% in August vs July EB Eventbrite $22.73 / -0.12 (-0.53%) 12/16/20 JPMorgan Eventbrite price target raised to $15 from $10 at JPMorgan 05/18/20 Fly Intel: Top five analyst upgrades 05/18/20 SunTrust Eventbrite upgraded to Buy at SunTrust on valuation 05/18/20 SunTrust Eventbrite upgraded to Buy from Hold at SunTrust EB Eventbrite $22.73 / -0.12 (-0.53%) 02/25/21 Eventbrite reports Q4 EPS (22c) consensus (37c) 11/05/20 Eventbrite reports Q3 EPS (21c), consensus (41c) EB Eventbrite $22.73 / -0.12 (-0.53%) 02/25/21 Fly Intel: After-Hours Movers 11/09/20 Fly Intel: Wall Street's top stories for Monday 11/09/20 Fly Intel: Wall Street's top stories at midday
Hot Stocks	Terns to report data from Phase 2a LIFT study of TERN-101 in 3Q21 » 07:10 03/08/21 03/08 07:10 03/08/21 07:10 TERN Terns Pharmaceuticals $17.13 / -1.81 (-9.56%) Terns Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly TERN Terns Pharmaceuticals $17.13 / -1.81 (-9.56%) 03/02/21 Cowen Terns initiated with Outperform on NASH potential at Cowen 03/02/21 JPMorgan Terns Pharmaceuticals initiated with an Overweight at JPMorgan 03/02/21 Cowen Terns Pharmaceuticals initiated with an Outperform at Cowen 03/02/21 Goldman Sachs Terns Pharmaceuticals initiated with a Buy at Goldman Sachs 05 Feb TERN Terns Pharmaceuticals $17.13 / -1.81 (-9.56%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech
Initiation	Signify Health initiated with a Buy at Deutsche Bank » 07:10 03/08/21 03/08 07:10 03/08/21 07:10 SGFY Signify Health $28.30 / +0.57 (+2.06%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly Options SGFY Signify Health $28.30 / +0.57 (+2.06%) 07:01 Today William Blair Signify Health initiated with an Outperform at William Blair 06:40 Today UBS Signify Health initiated with a Neutral at UBS 06:03 Today BofA Signify Health initiated with Buy at BofA 05:03 Today Goldman Sachs Signify Health initiated with a Neutral at Goldman Sachs 11 Feb SGFY Signify Health $28.30 / +0.57 (+2.06%) 02/14/21 Opening Day: Bumble, Viant soar in market debuts SGFY Signify Health $28.30 / +0.57 (+2.06%) 02/26/21 Eleven new option listings on February 26th

Upgrade	Verisk Analytics upgraded to Buy from Hold at Deutsche Bank » 07:10 03/08/21 03/08 07:10 03/08/21 07:10 VRSK Verisk Analytics $168.14 / +6.56 (+4.06%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly VRSK Verisk Analytics $168.14 / +6.56 (+4.06%) 02/18/21 Verisk Analytics appoints Kathy Card Beckles as general counsel 02/09/21 Universal Property expands underwriting, claims analytics with Verisk 02/04/21 Verisk Analytics, Plnar announce integration to enhance virtual claims adjusting 12/15/20 Verisk Analytics to acquire behavioral data company Jornaya; terms not disclosed VRSK Verisk Analytics $168.14 / +6.56 (+4.06%) 05:47 Today Raymond James Verisk Analytics upgraded to Outperform from Market Perform at Raymond James 03/01/21 Fly Intel: Top five analyst upgrades 03/01/21 UBS Verisk Analytics upgraded to Neutral from Sell at UBS 12/17/20 Barclays Verisk Analytics price target raised to $250 from $220 at Barclays VRSK Verisk Analytics $168.14 / +6.56 (+4.06%) 02/23/21 Verisk Analytics reports Q4 EPS $1.27, consensus $1.30 02/23/21 Notable companies reporting after market close 11/04/20 Verisk Analytics reports Q3 adjusted EPS $1.32, consensus $1.20 11/04/20 Notable companies reporting after market close VRSK Verisk Analytics $168.14 / +6.56 (+4.06%) 02/23/21 Fly Intel: After-Hours Movers
Hot Stocks	Global Blue acquires ZigZag SaaS technology platform » 07:10 03/08/21 03/08 07:10 03/08/21 07:10 GB Global Blue $11.75 / -0.05 (-0.42%) Global Blue announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News GB Global Blue $11.75 / -0.05 (-0.42%) 11/13/20 Third Point takes stake in PG&E, boosts Alibaba stake, exits Baxter 10/09/20 Global Blue falls -6.0% 09/18/20 Global Blue falls -4.6%
Hot Stocks	XL Fleet refutes 'inaccurate and misinformed' report by short-seller » 07:09 03/08/21 03/08 07:09 03/08/21 07:09 XL XL Fleet $11.16 / -0.88 (-7.31%) XL Fleet responded to a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Events Options XL XL Fleet $11.16 / -0.88 (-7.31%) 03/04/21 XL Fleet responds to recent short seller report, says conclusions 'flawed' 03/03/21 Muddy Waters short XL Fleet, doubts it will be serious player in electrification 03/03/21 XL Fleet down 16% after Muddy Waters publishes short report 03/03/21 XL Fleet down 16% to $13.36 in afternoon trading XL XL Fleet $11.16 / -0.88 (-7.31%) 01/29/21 Canaccord Canaccord sees XL Fleet going to $30 per share on 'first-mover' advantage 01/29/21 Canaccord XL Fleet initiated with a Buy at Canaccord 01/22/21 Fly Intel: Top five analyst initiations 01/22/21 BTIG XL Fleet initiated with a Buy at BTIG XL XL Fleet $11.16 / -0.88 (-7.31%) 12/23/20 XL Fleet jumps after Citron puts $60 price target on shares 12/23/20 Citron announces long position in XL Fleet with $60 price target 03/09/21 Sustainable Energy & Technology Virtual Conference 03/19/21 Electric Truck Day 03/30/21 XL Fleet - XL XL XL Fleet $11.16 / -0.88 (-7.31%) 03/03/21 Unusually active option classes on open March 3rd 03/02/21 XL Fleet call volume above normal and directionally bullish 03/02/21 Unusually active option classes on open March 2nd 03/01/21 XL Fleet call volume above normal and directionally bullish
Hot Stocks	Aravive doses first patient in Phase 1b/2 trial of AVB-500 » 07:09 03/08/21 03/08 07:09 03/08/21 07:09 ARAV Aravive $6.46 / -0.17 (-2.56%) Aravive announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ARAV Aravive $6.46 / -0.17 (-2.56%) 12/31/20 Aravive's Tabibiazar transitions from board member to advisor 11/19/20 Aravive announces Phase 3 trial design for AVB-500 in PROC 11/10/20 Aravive announces strategic collaboration with 3D Medicines 09/17/20 Aravive appoints Michael Rogers to board of directors ARAV Aravive $6.46 / -0.17 (-2.56%) 02/17/21 Piper Sandler Aravive chairman bought $21M of shares, says Piper Sandler 11/10/20 Piper Sandler Aravive Phase 1B data 'compelling,' says Piper Sandler 11/08/20 Piper Sandler Aravive price target lowered to $20 from $31 at Piper Sandler 09/18/20 Fly Intel: Top five analyst initiations ARAV Aravive $6.46 / -0.17 (-2.56%) 11/05/20 Aravive reports Q3 EPS (66c), consensus (42c)
Hot Stocks	Bio-Techne announces ExoTRU kidney transplant rejection assay data publication » 07:09 03/08/21 03/08 07:09 03/08/21 07:09 TECH Bio-Techne $355.44 / +4.44 (+1.26%) Bio-Techne announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings TECH Bio-Techne $355.44 / +4.44 (+1.26%) 03/03/21 Bio-Techne to acquire Asuragen for initial consideration of $215M in cash 03/01/21 Bio-Techne's Exosome Diagnostics laboratory announces contract with Humana 02/23/21 Bio-Techne, Luminary Therapeutics sign license agreement for us of TcBuster 02/08/21 Kantaro Biosciences signs marketing and distribution agreement with Atrys TECH Bio-Techne $355.44 / +4.44 (+1.26%) 06:34 Today Stephens Bio-Techne upgraded to Overweight from Equal Weight at Stephens 02/23/21 Stifel Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance 02/23/21 Stifel Bio-Techne upgraded to Buy from Hold at Stifel 02/03/21 Craig-Hallum Bio-Techne price target raised to $440 from $352 at Craig-Hallum TECH Bio-Techne $355.44 / +4.44 (+1.26%) 02/02/21 Bio-Techne reports Q2 non-GAAP EPS $1.62, consensus $1.37 11/05/20 Bio-Techne reports Q1 adj. EPS $1.43, consensus $1.09

Initiation	Chicken Soup for the Soul initiated with a Buy at Alliance Global Partners » 07:09 03/08/21 03/08 07:09 03/08/21 07:09 CSSE Chicken Soup for the Soul $23.80 / +0.05 (+0.21%) , CURI CuriosityStream $14.61 / -0.55 (-3.63%) , FUBO FuboTV $30.01 / -2.32 (-7.18%) Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options CSSE CURI FUBO CSSE Chicken Soup for the Soul $23.80 / +0.05 (+0.21%) 03/03/21 Chicken Soup for the Soul's Screen Media acquires U.S. rights to 'Eat Wheaties!' 02/22/21 Screen Media acquires worldwide distribution rights to new series 02/10/21 Chicken Soup for the Soul enters agreement to launch Crackle app on Smart TVs 12/18/20 Chicken Soup's Screen Media acquires 'Street Gang: How We Got to Sesame Street' CURI CuriosityStream $14.61 / -0.55 (-3.63%) 10/14/20 CuriosityStream to begin trading on Nasdaq with ticker 'CURI' after closing deal FUBO FuboTV $30.01 / -2.32 (-7.18%) 03/03/21 FuboTV falls -12.4% 03/03/21 FuboTV falls -14.3% 03/03/21 FuboTV falls -13.0% 03/02/21 FuboTV falls 5% to $39.91 after Q4 earnings miss CSSE CURI FUBO CSSE Chicken Soup for the Soul $23.80 / +0.05 (+0.21%) 12/16/20 Benchmark Chicken Soup for the Soul price target raised to $25 from $20 at Benchmark 12/16/20 Craig-Hallum Chicken Soup for the Soul price target raised to $30 from $25 at Craig-Hallum 11/16/20 National Securities Chicken Soup for the Soul downgraded to Neutral from Buy at National Securities 10/26/20 Craig-Hallum Craig-Hallum bullish on Chicken Soup for the Soul, initiates with a Buy CURI CuriosityStream $14.61 / -0.55 (-3.63%) 03/03/21 Fly Intel: Top five analyst initiations 03/03/21 Needham CuriosityStream initiated with a Buy at Needham 03/03/21 Needham CuriosityStream initiated with a Buy at Needham 02/16/21 Fly Intel: Top five analyst initiations FUBO FuboTV $30.01 / -2.32 (-7.18%) 03/03/21 Evercore ISI FuboTV price target raised to $42 from $32 at Evercore ISI 03/03/21 Oppenheimer FuboTV price target raised to $45 from $30 at Oppenheimer 03/03/21 BMO Capital FuboTV price target lowered to $45 from $50 at BMO Capital 02/01/21 Wedbush FuboTV price target raised to $50 from $40 at Wedbush FUBO FUBO FuboTV $30.01 / -2.32 (-7.18%) 03/02/21 FuboTV raises FY21 revenue view to $460M-$470M from $415M-$435M 03/02/21 FuboTV sees Q1 revenue $101M-$103M, consensus $99.36M 03/02/21 FuboTV reports Q4 EPS ($2.47), consensus (73c) 01/05/21 FuboTV reports preliminary Q4 revenue $94M-$98M, consensus $87.36M 04 Feb 30 Dec 08 Oct CURI FUBO CURI CuriosityStream $14.61 / -0.55 (-3.63%) 02/01/21 Fly Intel: After-Hours Movers 01/06/21 Fly Intel: Pre-market Movers FUBO FuboTV $30.01 / -2.32 (-7.18%) 03/02/21 Fly Intel: After-Hours Movers 02/16/21 Fly Intel: After-Hours Movers 01/21/21 FuboTV jumps as Barrington says buy, Einhorn highlights gains 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 00:00 Today Media, Internet and Telecom Virtual Conference 03/16/21 Play to Win Virtual Conference 03/23/21 CuriosityStream - CURI CURI FUBO CURI CuriosityStream $14.61 / -0.55 (-3.63%) 01/21/21 Eighteen new option listings and one option delisting on January 21st FUBO FuboTV $30.01 / -2.32 (-7.18%) 01/12/21 Unusually active option classes on open January 12th 01/05/21 Largest borrow rate increases among liquid names 01/04/21 Largest borrow rate increases among liquid names 12/30/20 Unusually active option classes on open December 30th
Recommendations	Magnite weakness a buying opportunity, says Susquehanna » 07:07 03/08/21 03/08 07:07 03/08/21 07:07 MGNI Magnite $39.12 / -1.28 (-3.17%) , GOOG Alphabet $2,107.85 / +62.095 (+3.04%) Susquehanna analyst Shyam… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MGNI GOOG MGNI Magnite $39.12 / -1.28 (-3.17%) 02/05/21 Magnite to acquire SpotX from RTL Group for $1.17B in cash, stock 11/17/20 Magnite sees total connected TV revenue up over 50% in Q3 09/29/20 Magnite announces expanded relationship with Discovery for advertising 09/22/20 Magnite names Katie Evans as COO GOOG Alphabet $2,107.85 / +62.095 (+3.04%) 03/05/21 ChannelAdvisor to join Google Partners International Growth program 03/03/21 Google backs plan to remove support for third-party cookies in Chrome 02/25/21 MongoDB expands integration of Atlas database with Google Cloud 02/25/21 Schrodinger expands collaboration with Google Cloud MGNI GOOG MGNI Magnite $39.12 / -1.28 (-3.17%) 02/25/21 Craig-Hallum Magnite price target raised to $72 from $63 at Craig-Hallum 02/09/21 Needham Needham names Magnite 'top pick' for 2021, raises price target to $70 02/05/21 Susquehanna Magnite deal bolsters status as top independent SSP for CTV, says Susquehanna 01/28/21 B. Riley Securities Magnite transferred with Neutral from Buy at B. Riley Securities GOOG Alphabet $2,107.85 / +62.095 (+3.04%) 06:43 Today KeyBanc Trade Desk upgraded to Overweight from Sector Weight at KeyBanc 03/03/21 Jefferies Google Cloud traction under Kurian 'under-appreciated,' says Jefferies 02/17/21 Morgan Stanley Roku price target raised to $275 from $200 at Morgan Stanley 02/12/21 Citi Citi boosts Alphabet target but shares no longer a top pick MGNI GOOG MGNI Magnite $39.12 / -1.28 (-3.17%) 02/24/21 Magnite reports Q4 adjusted EPS 19c, consensus 14c 11/09/20 Magnite sees Q4 revenue $72M-$75M, consensus $66.81M 11/09/20 Magnite reports Q3 EPS 6c, consensus (4c) GOOG Alphabet $2,107.85 / +62.095 (+3.04%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/02/21 Alphabet reports Q4 EPS $22.30, consensus $15.90 02/02/21 Notable companies reporting after market close 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago MGNI GOOG MGNI Magnite $39.12 / -1.28 (-3.17%) 01/07/21 Spruce Point names Magnite 'strong sell,' sees up to 50% downside for shares 01/07/21 Magnite named as short idea at Spruce Point, sees 50% downside GOOG Alphabet $2,107.85 / +62.095 (+3.04%) 03/05/21 Trade Desk challenging Google in digital-advertising tech world, WSJ reports 03/05/21 YouTube to lift Trump's suspension when risk of violence drops, CNBC reports 03/04/21 Microsoft president Smith to testify at 'Big Tech' antitrust hearing, Axios says 03/03/21 Apple and Alphabet may hindered by new Arizona app payment rules. Verge says MGNI GOOG MGNI Magnite $39.12 / -1.28 (-3.17%) 02/05/21 Fly Intel: Pre-market Movers 01/25/21 Fly Intel: Wall Street's top stories at midday 01/07/21 Fly Intel: Wall Street's top stories for Thursday 01/07/21 Fly Intel: Wall Street's top stories at midday GOOG Alphabet $2,107.85 / +62.095 (+3.04%) 03/02/21 Game On: GameStop CFO resigns, EA ceases new development on 'Anthem' 02/24/21 #SocialStocks: Snap shares advance following first investor day 02/24/21 Fly Intel: What to watch in Nvidia earnings report 02/23/21 Game On: An exclusive talk with Skeleton Crew's Olsson and Murakami MGNI GOOG MGNI Magnite $39.12 / -1.28 (-3.17%) 02/04/21 Magnite rally attracts $6 million put buyer 01/07/21 Magnite Inc put volume heavy and directionally bearish 11/25/20 Magnite Inc call volume above normal and directionally bullish GOOG Alphabet $2,107.85 / +62.095 (+3.04%) 02/02/21 Alphabet options imply 6.6% move in share price post-earnings 11/10/20 Alphabet call volume above normal and directionally bullish 10/30/20 Early notable gainers among liquid option names on October 30th
Hot Stocks	Moderna announces Shannon Klinger as chief legal officer » 07:07 03/08/21 03/08 07:07 03/08/21 07:07 MRNA Moderna $132.22 / +0.01 (+0.01%) , NVS Novartis $84.09 / +0.67 (+0.80%) Moderna (MRNA) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRNA NVS MRNA Moderna $132.22 / +0.01 (+0.01%) 03/07/21 Moderna to provide 13M doses of COVID vaccine to Philippines 03/05/21 Moderna announces Takeda NDA submission to distribute COVID-19 vaccine in Japan 03/04/21 Moderna, IBM to collaborate on COVID vaccine supply, distribution data sharing 03/04/21 GC Pharma to support Moderna distribution of 40M doses of COVID-19 Vaccine NVS Novartis $84.09 / +0.67 (+0.80%) 03/05/21 Novartis Chief Legal Officer Shannon Klinger to resign 03/04/21 CureVac and Novartis in initial pact on Covid vaccine candidate 03/02/21 Novartis shareholders approve 1.7% increase in dividend to CHF 3.00 per share 03/01/21 Homology Medicines regains worldwide rights to ophthalmology program MRNA NVS MRNA Moderna $132.22 / +0.01 (+0.01%) 03/01/21 Chardan Moderna price target raised to $182 from $107 at Chardan 02/26/21 Barclays Moderna price target raised to $178 from $169 at Barclays 02/26/21 Brookline Moderna price target raised to $205 from $180 at Brookline 02/25/21 Piper Sandler Moderna transitioning into profitable company, says Piper Sandler NVS Novartis $84.09 / +0.67 (+0.80%) 03/01/21 Oppenheimer Homology Medicines loses potential source of upside, says Oppenheimer 02/02/21 Morgan Stanley Novartis price target lowered to CHF 102 from CHF 104 at Morgan Stanley 02/01/21 Truist iRhythm price target lowered to $220 from $265 at Truist 02/01/21 Cowen Novartis downgraded to Market Perform after 'tepid' guidance at Cowen MRNA NVS MRNA Moderna $132.22 / +0.01 (+0.01%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) NVS Novartis $84.09 / +0.67 (+0.80%) 01/26/21 Novartis sees 2021 core operating income to grow mid single digit 01/26/21 Novartis reports Q4 core EPS $1.34, consensus $1.36 11/05/20 Xoma reports Q3 EPS (10c), consensus (21c) 10/27/20 Novartis raises FY20 core operating income growth outlook 19 May MRNA NVS MRNA Moderna $132.22 / +0.01 (+0.01%) 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports 02/28/21 AstraZeneca sells stake in Moderna for over $1B, The Times reports 02/17/21 Moderna to supply EU with another 150M vaccine doses in 2021, FT reports 02/12/21 FDA tells Moderna it can boost vaccine supply in each vial, NY Times reports NVS Novartis $84.09 / +0.67 (+0.80%) 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports MRNA NVS MRNA Moderna $132.22 / +0.01 (+0.01%) 02/25/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: After-Hours Movers 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday NVS Novartis $84.09 / +0.67 (+0.80%) 02/11/21 Fly Intel: Wall Street's top stories for Thursday 02/11/21 Fly Intel: Wall Street's top stories at midday 02/11/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks 03/16/21 31st Annual Healthcare Virtual Conference MRNA MRNA Moderna $132.22 / +0.01 (+0.01%) 03/01/21 Moderna call volume above normal and directionally bullish 02/01/21 Moderna call volume above normal and directionally bullish 01/25/21 Moderna call volume above normal and directionally bullish 12/17/20 Moderna call volume above normal and directionally bullish
Hot Stocks	II-VI revises proposal to acquire Coherent » 07:07 03/08/21 03/08 07:07 03/08/21 07:07 IIVI II-VI $74.61 / -1.01 (-1.34%) , COHR Coherent $235.07 / +2.01 (+0.86%) , LITE Lumentum $86.10 / +0.74 (+0.87%) II-VI Incorporated (IIVI)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options IIVI COHR LITE IIVI II-VI $74.61 / -1.01 (-1.34%) 06:57 Today Lumentum comments on Coherent notification of II-VI acquisition proposal 05:05 Today Coherent board determines II-VI revised proposal superior to Lumentum agreement 02/26/21 II-VI to double manufacturing capacity of optical filters 02/16/21 Coherent to engage in discussions with II-VI following acquisition proposal COHR Coherent $235.07 / +2.01 (+0.86%) 06:57 Today Lumentum comments on Coherent notification of II-VI acquisition proposal 05:05 Today Coherent board determines II-VI revised proposal superior to Lumentum agreement 02/16/21 Coherent to engage in discussions with II-VI following acquisition proposal 02/12/21 Coherent confirms receipt of unsolicited proposal from II-VI LITE Lumentum $86.10 / +0.74 (+0.87%) 06:57 Today Lumentum comments on Coherent notification of II-VI acquisition proposal 05:05 Today Coherent board determines II-VI revised proposal superior to Lumentum agreement 02/16/21 Coherent to engage in discussions with II-VI following acquisition proposal 02/12/21 Coherent confirms receipt of unsolicited proposal from II-VI IIVI COHR LITE IIVI II-VI $74.61 / -1.01 (-1.34%) 02/12/21 Benchmark Benchmark maintains Buy rating on II-VI after Coherent bid 02/10/21 DA Davidson II-VI price target raised to $115 from $60 at DA Davidson 02/10/21 Cowen II-VI price target raised to $124 from $86 at Cowen 02/10/21 Canaccord II-VI price target raised to $152 from $86 at Canaccord COHR Coherent $235.07 / +2.01 (+0.86%) 02/12/21 Benchmark Benchmark maintains Buy rating on II-VI after Coherent bid 02/11/21 Benchmark Coherent downgraded to Hold from Buy at Benchmark 02/08/21 Stifel Coherent bid may force Lumentum to raise offer, says Stifel 02/08/21 Benchmark Coherent deal with MKS could face regulators' scrutiny, says Benchmark LITE Lumentum $86.10 / +0.74 (+0.87%) 02/12/21 Benchmark Benchmark maintains Buy rating on II-VI after Coherent bid 02/11/21 Benchmark Coherent downgraded to Hold from Buy at Benchmark 02/08/21 Stifel Coherent bid may force Lumentum to raise offer, says Stifel 02/08/21 Benchmark Coherent deal with MKS could face regulators' scrutiny, says Benchmark IIVI COHR LITE IIVI II-VI $74.61 / -1.01 (-1.34%) 02/09/21 II-VI sees Q3 adjusted EPS 81c-91c, consensus 82c 02/09/21 II-VI reports Q2 adjusted EPS $1.08, consensus 91c 02/08/21 Notable companies reporting before tomorrow's open 02/08/21 Notable companies reporting before tomorrow's open COHR Coherent $235.07 / +2.01 (+0.86%) 02/10/21 Coherent reports Q1 adjusted EPS $1.09, consensus 89c 01/19/21 Coherent reports preliminary Q1 revenue $325M-$327M, consensus $313.09M 11/10/20 Coherent sees Q1 revenue $300M-$320M, consensus $341.28M 11/10/20 Coherent reports Q4 adjusted EPS $1.01, consensus 80c LITE Lumentum $86.10 / +0.74 (+0.87%) 02/02/21 Lumentum sees Q3 non-GAAP EPS $1.31-$1.46, consensus $1.32 02/02/21 Lumentum reports Q2 non-GAAP EPS $1.99, consensus $1.90 02/01/21 Notable companies reporting before tomorrow's open 02/01/21 Notable companies reporting before tomorrow's open 02 Jul IIVI COHR LITE IIVI II-VI $74.61 / -1.01 (-1.34%) 02/12/21 II-VI plans to bid $260 a share for Coherent, WSJ reports 12/18/20 II-VI to enter supply chain for Apple's next-gen iPhones, DigiTimes reports 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says COHR Coherent $235.07 / +2.01 (+0.86%) 02/12/21 II-VI plans to bid $260 a share for Coherent, WSJ reports 01/19/21 NeoPhotonics speculated as potential takeover target at Dealreporter 01/18/21 Lumentum in advanced talks to acquire Coherent, WSJ reports LITE Lumentum $86.10 / +0.74 (+0.87%) 02/12/21 II-VI plans to bid $260 a share for Coherent, WSJ reports 01/19/21 NeoPhotonics speculated as potential takeover target at Dealreporter 01/18/21 Lumentum in advanced talks to acquire Coherent, WSJ reports 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports IIVI COHR LITE IIVI II-VI $74.61 / -1.01 (-1.34%) 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday 02/09/21 Fly Intel: Pre-market Movers 11/05/20 Fly Intel: Pre-market Movers COHR Coherent $235.07 / +2.01 (+0.86%) 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Fly Intel: Wall Street's top stories for Monday 02/08/21 Fly Intel: Wall Street's top stories at midday LITE Lumentum $86.10 / +0.74 (+0.87%) 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday 01/20/21 Street Fight: Analysts diverge on Lumentum after Coherent deal announcement 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference LITE LITE Lumentum $86.10 / +0.74 (+0.87%) 02/11/21 Lumentum call volume above normal and directionally bullish 01/05/21 Lumentum call volume above normal and directionally bullish
Hot Stocks	ISS recommends NTN stockholders vote 'FOR' proposed merger, asset sale » 07:06 03/08/21 03/08 07:06 03/08/21 07:06 NTN NTN Buzztime $3.12 / -0.26 (-7.69%) NTN Buzztime announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Events NTN NTN Buzztime $3.12 / -0.26 (-7.69%) 03/01/21 NTN Buzztime board urges shareholders to vote for proposed merger, asset sale 02/18/21 Ault Global Holdings acquires 9.96% equity interest in NTN Buzztime 01/15/21 NTN Buzztime receives noncompliance notice from NYSE American 09/18/20 NTN Buzztime sells entertainment, advertising assets for $2M 03/15/21 NTN Buzztime, Inc.

Events

Earnings calls, analyst events, roadshows and more

XPEV
Today at 08:00

Xpeng - XPEV Conference Calls
NIU
Today at 08:00

Niu Technologies - NIU Conference Calls
NERV
Today at 08:30

Minerva - NERV Conference Calls
CI
Today at 08:30

CIGNA Corporation Firm Sponsored Meetings
ABCM
Today at 09:00

Abcam - ABCM Conference Calls
Today at 10:00

Wholesale Inventories (Preliminary) M/M: January 2021 Government Event
MGIC
Today at 10:00

Magic Software - MGIC Conference Calls
FOLD
Today at 10:00

Amicus - FOLD Conference Calls
NINE
Today at 10:00

Nine Energy Service - NINE Conference Calls
PERI
Today at 10:00

Perion Network Ltd. Firm Sponsored Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	CPNG X CPNG Coupang IPO Managers: Goldman Sachs, Allen & Co., JPMorgan & BofA, HSBC, Deutsche Bank, UBS, MIZU, CLSA $27.00-30.00 120M Shares GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HAYW X HAYW Hayward IPO Managers: BofA, Goldman Sachs & Nomura, Credit Suisse, Morgan Stanley, Baird, Guggenheim, Jefferies, BMO Capital, KeyBanc, William Blair, HOUL, Moelis $17.00-19.00 40.278M Shares
Thurs	JOAN X JOAN Joann IPO Managers: BofA & Credit Suisse, Guggenheim, Barclays, Wells Fargo, Piper Sandler, William Blair, HOUL, Telsey Advisory, Loop Capital, Ramirez $15.00-17.00 10.94M Shares
Fri	No deals

View All Syndicate Announcements »

Medallion Financial reports Q4 EPS 26c, consensus 25c

TODAY'S FREE FLY STORIES

Get Full Fly Access